M&A Advisors in New York

Background: Before agreeing to invest money, conduct technical due diligence. We consolidate the extensive knowledge and rich hands-on experience of the best industry experts in the following areas: - Penetration testing and vulnerability assessment, - Performance and load testing, - Secure SDLC implementation, - Cloud infrastructure scalability testing and cost optimization. On the platform, we are acting as advisors. We have clients from multiple locations. We will charge upfront and closure fees.

Background: We are an M&A advisory firm based in Tel Aviv, Israel. We specialize in business consulting and advisory services to clients in Israel. We cater to healthcare and industrial businesses. We charge both an upfront fee and a success fee.

Background: Boutique investment bank based in Oslo, Norway. Licensed by the UK Financial Conduct Authority. Expertise in M&A transactions and company restructuring. On the platform, I am looking to be an advisory or investment opportunities.

Background: Boutique investment bank based in Oslo, Norway. Licensed by the UK Financial Conduct Authority. Expertise in M&A transactions and company restructuring. On the platform, I am looking to be an advisory or investment opportunities.

Background: A subsidiary of an enterprise founded in 1993 and headquartered in Beijing, we are a leading investment, operation, and management group in China, with a presence in over 50 countries globally and annual sales of approximately RMB200 bn (c. US$30.8 bn1). • The pharmaceutical and healthcare business represents a core. Focus area for the group and comprises 40+ companies with total sales of. RMB38 bn (US$5.8 bn) in 2017. • On a consolidated basis, we ranked among the top 5 manufacturers by sales in the Chinese pharmaceutical market in 2017. • We have established four major industrial platforms: (i) Generic pharma; (ii) Specialty pharma; (iii) Traditional Chinese Medicine (TCM); and (iv) bio-pharmaceuticals. Our focus is a cross-border and domestic license (license-in, including both clinical stage and commercial-stage products), tech transfer, acquisition, distribution, and co-development of live biotherapeutic products, and investment in novel microbiome Research platforms.

Background: We are a business consulting and advisory firm. We do not charge upfront fee. We charge only success fee post the deal closure.

Background: We provide advisory services in the M&A segment to our clients. We do not charge an upfront fee. We do charge a success fee. Our clients are interested in business opportunities in North America, Europe and Germany as it is convenient for them to collaborate with businesses in these countries.